Author(s):
Sangeeta Mukhi, Anindya Bose, Dilip Kumar Das, Sitansu Kumar Panda, Debahuti Mohapatra, S. Latha, Ashok Kumar Balaraman
Email(s):
anindyabose_in@yahoo.com
DOI:
10.52711/0974-360X.2021.00543
Address:
Sangeeta Mukhi1, Anindya Bose1, Dilip Kumar Das2, Sitansu Kumar Panda3, Debahuti Mohapatra4, S. Latha5, Ashok Kumar Balaraman6
1Department of Pharmaceutical Analysis, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar - 751003, Odisha, India.
2Department of Pathology, Hi-Tech Medical College, Bhubaneswar, Odisha, India.
3Department of Anatomy, Institute of Medical Sciences and SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
4Department of Pathology, Institute of Medical Sciences and SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar, Odisha, India.
5Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research, Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu, India.
6Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
*Correspondin
Published In:
Volume - 14,
Issue - 6,
Year - 2021
Cite this article:
Sangeeta Mukhi, Anindya Bose, Dilip Kumar Das, Sitansu Kumar Panda, Debahuti Mohapatra, S. Latha, Ashok Kumar Balaraman. Acute and Sub-acute Toxicity study of Amrtadi Churna. Research Journal of Pharmacy and Technology. 2021; 14(6):3111-8. doi: 10.52711/0974-360X.2021.00543